EUCTR2006-003539-56-AT进行中（未招募）1 期
Simvastatin in patients with septic shock
Medical University of Vienna, Department of Internal Medicine IV0 个研究点目标入组 40 人开始时间: 2006年10月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Patients aged more than 18 years
- •-Presence of septic shock for less than 48 hours
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-hemorrhagic shock
- •-High risk of rhabdomyolysis (multiple trauma, crush injuries, extensive
- •burns, baseline creatinine kinase (CK) =ten-times upper limit of normal
- •-History of known or suspected porphyria
- •-expected survival of less than 72 hours
- •-Treatment in the previous 3 weeks with simvastatin or other HMG-CoA
- •reductase inhibitors
- •-History of hypersensitivity to the trial drug or to drugs with a similar
- •chemical structure
- •-unable to receive enteral medications
- •-pregnancy
研究者
相似试验
进行中（未招募）
1 期
SimSepT: Simvastatin and severe sepsis in the ICU - SimSepTSevere sepsisEUCTR2005-003438-17-GBOxford Radcliffe Hospitals NHS Trust200
已完成
不适用
Simvastatin and severe sepsisSevere sepsisInfections and InfestationsSepticaemiaISRCTN92093279Oxford Radcliffe Hospitals NHS Trust (UK)104
Unknown
4 期
Simvastatin in Patients With Septic ShockSeptic ShockNCT00450840Medical University of Vienna
已完成
2 期
Statin Therapy in the Treatment of SepsisSeptic ShockNCT00676897Beth Israel Deaconess Medical Center18
已完成
不适用
Simvastatin in community-acquired pneumoniaCommunity-acquired pneumoniaISRCTN91327214The Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)376